Papillary thyroid carcinomas (PTC) frequently harbor activating rearrangements of RET (8–33%) or NTRK1 (5–15%) genes, both coding for receptor tyrosine kinases that exert control over a wide range of transcription factors [3]. The gene discussed is NTRK1; the disease is differentiated thyroid carcinoma.